Searched for
PHARMA IPO INDIA
Falling crude, stronger rupee could boost earnings outlook for India: Deepak ShenoyIndian stocks are poised for a favorable period. Falling crude oil prices and a strengthening rupee offer support. Macroeconomic conditions...- Ahead of Market: 10 things that will decide stock market action on MondayMarkets rallied sharply as easing US–Iran tensions and softer crude prices boosted sentiment. Sensex and Nifty surged 2%, adding Rs 10 lakh...
- Japanese investors are looking beyond China... India is key alternative: Tsutomu Takemura, Senior MD, NomuraIndia is increasingly becoming a long-term structural investment destination rather than a short-term strategic bet. Global capital is movi...
- We expect interest rates to be left the way they are: Ficci chief Anant GoenkaFicci president Anant Goenka advocates for steady interest rates, citing supply-side price pressures from the West Asia crisis. He suggests...
- Ahead of Market: 10 things that will decide stock market action on WednesdayDomestic equity benchmarks ended lower on Tuesday, snapping a three-session rally amid profit booking in financial, realty and consumer sto...
- IPO investors brace for 73 lock-in expiries worth $34 billion in three months. Will your portfolio be impacted?India’s stock market is set for a wave of IPO lock-in expiries over the next three months, with shares worth $34 billion from 73 recently l...
- More companies may take confidential route to file IPO papersMore companies are choosing to file their initial public offering documents confidentially. This move is driven by uncertainty surrounding ...
- “Reallocate, Diversify, Reposition”: Ajay Srivastava flags rising macro risks for investorsIndian markets face rising macro risks from global shocks, currency pressure, and energy prices, impacting domestic consumption and corpora...
- MSMEs key to creating 20 lakh jobs in Andhra: Minister Nara LokeshThe government is promoting decentralized development through clusters and simplifying business processes. Plans are underway to list 100 A...
- IPO Calendar: 2 issues to keep investors busy but mainboard activity remains mutedIndia's primary market is set for a busy week with two SME IPOs. RFBL Flexi Pack and Goldline Pharmaceutical will open for subscription on ...
- IPO investors brace for 83 lock-in expiries worth $55 billion in three months. Do you own any?IPO investors are bracing for a significant wave of lock-in expiries between May and August, with shares of 83 newly-listed companies value...
- Rupee at 95, crude at $120+: Why India's markets are flying blind into a stormMarket expert Sudip Bandyopadhyay warns Indian markets face significant risks. High oil prices and a potential monsoon deficit are major co...
- Are metals turning defensive? 5-year returns rival, even beat traditional safe havensMetal stocks are outperforming defensive sectors, delivering strong returns driven by structural demand shifts and supply constraints. Fact...
- Bain Capital sole contender for Vitabiotics buyBain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...
- India's 30-year economic model is over; time to pivot from IT to manufacturing: Saurabh MukherjeaSaurabh Mukherjea believes India's long-standing economic model is concluding. He anticipates rising inflation and a weakening rupee impact...
- D-Street week ahead: Q4 earnings, Iran-US talks outcome to drive markets in truncated trading weekNifty posted its best weekly gain since February 2021, rising 6% on easing geopolitical tensions and falling volatility. Analysts see conti...
- Speciality Medicines IPO: SME stock to list today. Check price band, other detailsSpeciality Medicines shares debut on the BSE SME platform today. The company's IPO, a fresh issue, sought to raise approximately Rs 29 cror...
- Sai Parenteral IPO Day 3: 43% subscribed; here’s a look at GMP and key details; Should you invest?Sai Parenteral IPO saw 43% subscription on Day 3, with strong NII interest but weak retail participation. Despite no GMP indicating a flat ...
- Sai Parenteral’s IPO: Issue subscribed just 4% on day 1. Check price band, GMPSai Parenteral’s IPO opened with weak demand, subscribing just 4% on day one amid no grey market premium. While retail and NII interest rem...
- Gland Pharma IPO to open on Nov 9; price band fixed at Rs 1,490-1,500 per shareThe Gland Pharma IPO, India’s largest IPO in the pharmaceutical sector, comprises a fresh issue aggregating up to Rs 1,250 crore and an off...
Load More
